This is a non-interventional study
Sponsors
Dicerna Pharmaceuticals, Inc., Drug Safety Research Unit, Southampton, UK, Notable Labs, University Hospital, Grenoble, University of Malaya
Conditions
Acute Coronary SyndromeAcute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaAutoimmune hypothyroidism Underactive thyroid glandCOVID-19 PandemicChronic Myelogenous LeukemiaCritical IllnessDiabetic Peripheral Neuropathy
Unknown Phase
Rivaroxaban ACS Specialist Cohort Event Monitoring Study
CompletedNCT02673437
Start: 2015-09-30End: 2019-02-28Updated: 2019-04-24
Collect and Assess Tissue Samples From Subjects With Hematologic Malignancy
CompletedNCT04014764
Start: 2019-12-15End: 2022-03-31Updated: 2022-04-05
cDC1 Prognostic and Predictive Role in Non-Small-Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors
WithdrawnNCT04069442
Start: 2020-06-30End: 2020-09-30Updated: 2021-04-01
LRRK2 G2385R Leucocyte and Urine Biomarker Study
NCT04436848
Start: 2020-06-01End: 2022-06-30Target: 150Updated: 2020-06-18
Singapore's Health Outcomes After Critical Illness in Kids
CompletedNCT04637113
Start: 2021-01-14End: 2023-12-31Updated: 2024-11-07
Exploring the Immunology of Sarcoidosis
CompletedNCT04637165
Start: 2019-11-11End: 2023-12-31Updated: 2024-10-02
Understanding Fabry Disease Therapy Choices Through the Eyes of the Patients
CompletedNCT04804566
Start: 2023-03-01End: 2023-11-01Updated: 2024-04-03
Microvascular Dysfunction in Diabetic Peripheral Neuropathy
NCT05118217
Start: 2021-11-18End: 2022-04-30Target: 72Updated: 2021-11-11
Towards Better Preparedness for Future Catastrophes - Local Lessons-learned From COVID-19
CompletedNCT05552989
Start: 2022-09-23End: 2023-06-21Updated: 2023-11-29
A Natural History Study of Patients with Genetically Confirmed Primary Hyperoxaluria Type 3 with a History of Stone Events
Active, not recruitingLBCTR2021054742
Start: 2021-06-15Target: 480Updated: 2026-02-02
A Multi-Site Leukopak Repository Providing Annotated Biospecimens for Approved Investigator-Directed Biomedical Research Initiatives
RecruitingNCT05794217
Start: 2022-09-28End: 2026-12-31Target: 20000Updated: 2024-12-06
Development of the Work In Progress Questionnaire
RecruitingNCT05932043
Start: 2023-07-10End: 2024-02-29Target: 100Updated: 2024-01-10
Translation, Cultural Adaptation and Validation of the Italian Version of Functional Rating Index in Patients With Chronic Low Back Pain
CompletedNCT06793254
Start: 2022-06-01End: 2025-01-19Updated: 2025-01-27
THYROIDAL
Active, not recruitingNL-OMON61518
Start: 2026-09-11Target: 600Updated: 2026-08-31